Planned Parenthood has been taking taxpayer dollars while selling its pharmaceutical affiliate’s birth control pills, the American Action League (ALL) wrote in its preliminary report on the “Planned Parenthood – Afaxys Connection” published July 6.
ALL, American’s largest Catholic pro-life organization, casts doubt on the relationship between pharmaceutical company Afaxys — which manages supply needs for public health providers including university, family planning, and community health clinics — and Planned Parenthood.
“Planned Parenthood has created its own for-profit company to market dangerous birth control chemicals that can kill the preborn and maim women,” Judie Brown, ALL president and co-founder, told Church Militant Tuesday. “We are not surprised with this new information … money is the only thing they care about.”
Ronda Dean, the co-founder and CEO of Afaxys, is a former vice president of Planned Parenthood, and former Planned Parenthood executives fill many of the company’s management positions, including spots at Afaxys’ parent company 416 Holdings, Inc., according to ALL’s document. The report states that multiple Planned Parenthood affiliates gave money to Afaxys in return for company stock.
Western Pennsylvania Planned Parenthood clinics have branded Afaxys as a “Planned Parenthood affiliated company,” making the 340B Drug Pricing Program — which grants certain health care providers discounts on prescription drugs — especially suspect in ALL’s opinion, given Planned Parenthood’s relationship with Afaxys.
“The incestuous relationship between these organizations causes concern over taxpayer-funded 340B programs,” ALL executive director Jim Sedlak said. “As Congress appears to vote on taking direct taxpayer funding from Planned Parenthood, it has established this new relationship to keep taxpayer funding flowing through indirect channels.”
The report noted that the relationship between Planned Parenthood and Afaxys is “a concerted effort to make more money from the American taxpayer” because, as a 501(c)(3) nonprofit, Planned Parenthood should not be receiving indirect funds from a symbiotic agreement it holds with a particular pharmaceutical company.
Planned Parenthood brings in $127 million in profit per year despite being a nonprofit, the Daily Wire reported in December 2016. It appears now that some of these funds could be dishonest if ALL’s findings prove to be true.
“As Congress moves to shut off all direct funding of Planned Parenthood for the next year, we urge members of Congress to launch a full investigation of Afaxys and all Planned Parenthood’s ‘affiliated companies’ and end its indirect access to taxpayer funds,” ALL said.
Planned Parenthood did not return The Daily Caller News Foundation’s request for comment.
All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact licensing@dailycallernewsfoundation.org.
